On June 15, 2022, the United States Supreme Court issued a unanimous ruling (“Decision”) handing a substantial win to hospitals participating in the 340B program. In 2018, the Centers for Medicare and Medicaid [...]
FTLF’s 340B/Pharmacy Partners Michael B. Glomb and Jason B. Reddish will speak at the Annual 2022 340B Coalition Winter Conference next week in San Diego, CA. During the three-day conference, FTLF Partners will participate in the following sessions: Recapping [...]
FTLF Partner Jason Reddish will speak at three sessions during the Annual 340B Coalition Summer Conference. His presentations include: Jul 21, 2021 at 1:00PM - 1:50PM States Blazing a Trail Across the Nation [...]
On December 10, 2020, the Supreme Court ruled in a unanimous decision (8-0) in Rutledge v. Pharmaceutical Care Management Association (PCMA)[1] that an Arkansas law that requires Pharmacy Benefit Managers (PBMs) to reimburse [...]
Today, FTLF Partner Jason Reddish will present on recent 340B Drug Discount Program developments at the Illinois Primary Health Care Association (IPHCA) 2020 Virtual Leadership Conference. Mr. Reddish will discuss current and emerging [...]
HRSA’s Office of Pharmacy Affairs (OPA) has posted guidance for 340B covered entities during the COVID-19 pandemic. The guidance can be accessed on the HRSA OPA website at https://www.hrsa.gov/opa/COVID-19-resources. Some of the questions [...]
FTLF Partners Michael Glomb and Jason Reddish will participate in the 2020 340B Coalition Winter Conference next week in San Diego, CA. During the three-day conference, FTLF will present at the following sessions: Tuesday, February [...]
